Human challenge trials intentionally expose human subjects to a pathogen in order to test the efficacy and safety of a vaccine or therapeutic drug. The goal is to expedite the testing of a candidate treatment compared to the usual Phase III randomised controlled trial which often involve hundreds to thousands of patients and require years to complete.
This video visits FluCamp in the United Kingdom, which conducts trials of treatments for influenza, the common cold, asthma, and Respiratory Syncytial Virus (RSV). The trials involve randomised administration of virus and vaccine and placebos. A typical trial lasts 11–14 days, during which the participant is quarantined in a private room in the facility, regardless of whether they develop symptoms or not. Participants can be paid as much as £3750 for a two week study, with all meals included.
This is part of the careful process by which vaccines are tested for safety and effectiveness before being made available to the general public, unless unelected “public health” commissars decide to to dose 5.55 billion people with an untested genetic modification “vaccine” which doesn’t prevent either contracting or transmitting a novel disease.